36. (1) For the purposes of paragraph 4 of subsection 4 (1) of the Act, a member referred to in subsection (3) who complies with the other provisions of this section is authorized to perform the following acts: 1.  Adapting a patient’s prescription. 2.  Renewing a patient’s prescription for the purpose of continuity of care. O. Reg. 302/12, s. 1. (2) Subject to subsection (2.1), subsection (1) does not authorize a member referred to in subsection (3) to adapt or renew a prescription for a controlled substance as defined in the Controlled Drugs and Substances Act (Canada) or a drug designated as a monitored drug by the regulations under the Narcotics Safety and Awareness Act, 2010. O. Reg. 302/12, s. 1; O. Reg. 126/20, s. 2 (1). Note: On September 30, 2026, subsection 36 (2) of the Regulation is amended by striking out “Subject to subsection (2.1)” at the beginning. (See: O. Reg. 126/20, s. 2 (2) and O. Reg. 766/21, s. 2) (2.1) During the period of time in which the coronavirus exemption is in effect, subsection (2) does not apply to the extent that the coronavirus exemption or the Controlled Drugs and Substances Act (Canada) authorizes the member to adapt or renew a prescription for a controlled substance under that Act. O. Reg. 126/20, s. 2 (3). Note: On September 30, 2026, subsection 36 (2.1) of the Regulation is revoked. (See: O. Reg. 126/20, s. 2 (4) and O. Reg. 766/21, s. 2) (3) A Part A pharmacist, an intern or a registered pharmacy student is authorized to perform an act provided for in subsection (1), subject to the terms, conditions and limitations imposed on his or her certificate of registration. O. Reg. 302/12, s. 1. (4) A member may only perform an act provided for in subsection (1) if he or she complies with the following: 1.  The member must either possess the patient’s prescription to be adapted or renewed or, i.  receive a copy of the prescription directly from the pharmacy where the prescription was dispensed to the patient, ii.  be satisfied based on verbal confirmation from a pharmacist at the pharmacy where the prescription was dispensed to the patient as to the existence and details of the prescription, iii.  have access to the medical record that contains information about the prescription, or iv.  during the period of time in which the coronavirus exemption is in effect, if the criteria set out in subparagraphs i, ii and iii cannot be met, be satisfied as to the existence and details of the prescription from an alternative source, including, but not limited to, the prescription label, the prescription receipt with medication history, a photograph of the prescription or a facsimile of the prescription. Note: On September 30, 2026, paragraph 1 of subsection 36 (4) of the Regulation is amended by adding “or” at the end of subparagraph ii, by striking out “or” at the end of subparagraph iii and by revoking subparagraph iv. (See: O. Reg. 126/20, s. 2 (6) and O. Reg. 766/21, s. 2) 2.  If the member is renewing a prescription, he or she must not prescribe a quantity of the drug that exceeds the lesser of, i.  the quantity that was originally prescribed, including any refills that were authorized by the prescriber, and ii.  a 12 months’ supply. 3.  The member must, within a reasonable time, notify the prescriber identified on the prescription adapted or renewed by the member, as well as the patient’s primary care provider if the member knows that the patient has such a care provider other than the prescriber, providing details about the patient’s prescription, when the member, i.  renews a patient’s prescription, or ii.  adapts a patient’s prescription, if, in the member’s opinion, A.  adapting the prescription is clinically significant in relation to the patient, or B.  the notification is necessary to support the patient’s care. 4.  At the time that the member adapts or renews the patient’s prescription, the member must advise the patient or his or her authorized agent, i.  that he or she is entitled to the prescription, and ii.  that he or she may take the prescription to a pharmacy of his or her choosing for dispensing. 5.  The member must comply with the additional requirements under sections 37 and 38. O. Reg. 302/12, s. 1; O. Reg. 126/20, s. 2 (5); O. Reg. 742/20, s. 2.